What are the risk factors for developing a fistula in ano, particularly in adults with a history of anal abscesses or anorectal diseases such as Crohn's disease or ulcerative colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Risk Factors for Fistula in Ano

The primary risk factor for developing a fistula in ano is a preceding anorectal abscess, which leads to fistula formation in approximately 33-50% of cases, with Crohn's disease being the most important underlying disease predisposition. 1, 2

Major Risk Factors

Anorectal Abscess (Most Common)

  • The majority of anal fistulae arise from preexisting abscesses and represent a spectrum of the same cryptoglandular disease process. 3, 1
  • Anorectal abscesses result from infection of the intersphincteric anal glands, with obstruction of the draining duct producing infection that can rupture through the external sphincter. 3
  • The recurrence rate after simple abscess drainage can be as high as 44%, with inadequate drainage, loculations, and time from disease onset to incision being key risk factors for fistula development. 1
  • Approximately 40% of anorectal abscesses progress to fistula formation. 2

Crohn's Disease (Most Important Underlying Condition)

  • Perianal fistulae occur in 13-27% of patients with Crohn's disease, making it the most significant disease-associated risk factor. 3
  • Perianal fistulae may be the initial manifestation of Crohn's disease in up to 81% of patients who develop perianal disease. 3
  • In a small subset of patients, perianal fistula is the only manifestation of their Crohn's disease. 3
  • Complex and multifocal fistulae are more common in Crohn's disease compared to cryptoglandular fistulae. 3
  • Crohn's colitis is associated with anal lesions much more frequently than small bowel Crohn's disease (52% vs. 14%). 4
  • It is mandatory to exclude underlying Crohn's disease, especially with recurrent presentations, by assessing for inflammatory bowel disease symptoms including diarrhea, weight loss, and abdominal pain. 1

Additional Risk Factors

Infectious and Inflammatory Conditions

  • Radiation proctitis can predispose to fistula formation. 3
  • Specific infections including HIV, tuberculosis, and actinomycosis are associated with anal fistula development. 3

Iatrogenic and Traumatic Factors

  • Prior anal surgery increases fistula risk. 3
  • Foreign body penetration can lead to fistula formation. 3

Malignancy-Associated Risk

  • Approximately 11% of colovesical and colovaginal fistulae are caused by malignancy. 3
  • Carcinoma has been reported in association with anal fistulae in Crohn's disease, and carcinomas may rarely arise in chronic fistulae. 3

Demographic Risk Factors

  • Male sex (2:1 male-to-female ratio). 3
  • Mean age at presentation is 40 years. 3

Clinical Pitfalls to Avoid

  • When an anal lesion is the manifesting sign, Crohn's disease will soon develop elsewhere in the intestine, so physicians must always consider inflammatory bowel disease when dealing with suspicious anal lesions. 4
  • The absence of acute infection (no swelling, fever, or leukocytosis) suggests a chronic fistula rather than an active abscess. 1
  • Concern for malignancy should be raised when imaging shows a soft mass, mass-like thickening of the anorectal wall, or malignant-appearing lymphadenopathy during evaluation for suspected benign inflammatory disease. 3

References

Guideline

Diagnosis and Management of Intersphincteric Fistula

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anorectal infection: abscess-fistula.

Clinics in colon and rectal surgery, 2011

Guideline

acr appropriateness criteria® anorectal disease.

Journal of the American College of Radiology, 2021

Research

Anal complications in Crohn's disease.

Diseases of the colon and rectum, 1981

Related Questions

After fistulotomy healing, what new precautions should the patient follow to protect the anal sphincter and modify lifestyle?
What is the management and treatment of a fistula in ano in an adult patient with a history of anal abscesses or inflammatory bowel disease?
How do you manage high fistula output?
What is the recommended pain management for a patient with an anorectal abscess?
What could be causing a foul, inner rectal smell in a patient with a history of anal fistula, who recently underwent a fistulotomy and has no keyhole deformity?
How to titrate the dose of thyroxine (T4) in a patient already on the medication, considering their thyroid-stimulating hormone (TSH) levels and other medical conditions such as heart disease or osteoporosis?
What mood stabilizer can be added to a regimen of Adderall (amphetamine) and Vraylar (cariprazine) for a patient with bipolar disorder and a history of manic episodes characterized by euphoria, increased productivity, and reduced need for sleep, without psychosis or risky behaviors?
What diuretic regimen is recommended for a patient with pleural effusion, considering their medical history and renal function?
What causes frequent sores and irritation inside my nose, as well as redness, soreness, and swelling on the outside of my nose?
How to manage a cough in a patient with a tracheostomy, considering potential underlying conditions such as chronic obstructive pulmonary disease (COPD) or pneumonia?
What are the contraindications for using Imodium (Loperamide) in patients, particularly those with a history of inflammatory bowel disease, gastrointestinal surgery, or impaired cognitive function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.